Jani Huuhtanen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Eteläuomen läiJani huuhtanenSatu mustjokiCancer centerAalto universityUniversity of helsinkiTranslational immunology research programTranslational immunology research

Finnish Researchers Investigate Medication Discontinuation Success in Chronic Myeloid Leukaemia Patients

Finnish Researchers Investigate Medication Discontinuation Success in Chronic Myeloid Leukaemia Patients
news.europawire.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news.europawire.eu Daily Mail and Mail on Sunday newspapers.

Eteläuomen läiNorthern ostrobothniaSatu mustjokiJani huuhtanenAalto universityHelsinki university hospitalAne gyllenberg foundationUniversity of helsinkiResearch council of finlandEuropean research councilTranslational immunology research programCancer foundation finlandCancer centerChronic myeloid leukaemiaUniversity hospitalTranslational immunology research

Efficiency of Body s Defense System in the Diagnosis and Treatment of Skin Cancer Revealed via AI

Scientists from the University of Helsinki, Aalto University, HUS Comprehensive Cancer Center, and Stanford University have designed an artificial intelligence (AI) platform capable of predicting which patients with skin cancer will gain from a treatment that triggers the immune defense system.

Eteläuomen läiAlex smithSatu mustjokiJani huuhtanenNature communicationsUniversity of helsinkiAalto universityCancer centerMarkm davis lab at stanford universityStanford universityRight medicationDoctoral researcherTranslational hematology satu mustjokiAssociate professorComputational biologyMachine learning

AI model could be used to enable more effective care for skin cancer patients

The artificial intelligence model could be utilized to enable more effective care for skin cancer patients and could lead to similar breakthroughs in the diagnosis and treatment of other cancers.

Eteläuomen läiMarkm davisSatu mustjokiJani huuhtanenEmily hendersonNature communicationsUniversity of helsinkiAalto universityCancer centerStanford universityDoctoral researcherTranslational haematology satu mustjokiAssociate professorComputational biologySkin cancerArtificial intelligence

Nordic clinical trial opens the door to a cure for a blood cancer

A Nordic study run by HUS Comprehensive Cancer Center and the University of Helsinki examined how two different cancer treatments work better in combination rather than separately in patients. Chronic myeloid leukemia (CML) is one of the four main types of blood cancer, and it begins in the blood-forming cells of the bone marrow. Approximately 50 Finns are diagnosed with CML each year. It typically develops in people of working age.

Eteläuomen läiSatu mustjokiJani huuhtanenUniversity of helsinkiAalto universityHelsinki university hospitalChief physician satu mustjokiDoctoral researcher jani huuhtanenClinical investigation